{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,11]],"date-time":"2026-08-11T04:29:06Z","timestamp":1786422546126,"version":"build-2736575974"},"reference-count":34,"publisher":"Springer Science and Business Media LLC","issue":"8","license":[{"start":{"date-parts":[[2026,7,20]],"date-time":"2026-07-20T00:00:00Z","timestamp":1784505600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2026,7,20]],"date-time":"2026-07-20T00:00:00Z","timestamp":1784505600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Eur J Pediatr"],"DOI":"10.1007\/s00431-026-07245-2","type":"journal-article","created":{"date-parts":[[2026,7,20]],"date-time":"2026-07-20T14:51:25Z","timestamp":1784559085000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["The role of sclerostin and osteoprotegerin in bone metabolism in children with congenital adrenal hyperplasia"],"prefix":"10.1007","volume":"185","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-4116-5365","authenticated-orcid":false,"given":"G\u00fclay","family":"Karag\u00fczel","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4041-5561","authenticated-orcid":false,"given":"Esra Baki","family":"Erkul","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9474-4307","authenticated-orcid":false,"given":"Y\u00fcksel","family":"Aliyaz\u0131c\u0131o\u011flu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5948-7923","authenticated-orcid":false,"given":"Bircan","family":"S\u00f6nmez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4664-9070","authenticated-orcid":false,"given":"Naz\u0131m Erc\u00fcment","family":"Beyhun","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,7,20]]},"reference":[{"key":"7245_CR1","doi-asserted-by":"publisher","first-page":"91","DOI":"10.1210\/endrev\/bnab016","volume":"43","author":"HL Claahsen-van der Grinten","year":"2022","unstructured":"Claahsen-van der Grinten HL, Speiser PW, Ahmed SF, Arlt W, Auchus RJ, Falhammar H, Fl\u00fcck CE, Guasti L, Huebner A, Kortmann BBM, Krone N, Merke DP, Miller WL, Nordenstr\u00f6m A, Reisch N, Sandberg DE, Stikkelbroeck NMML, Touraine P, Utari A, Wudy SA, White PC (2022) Congenital adrenal hyperplasia-current insights in pathophysiology, diagnostics, and management. Endocr Rev 43:91\u2013159. https:\/\/doi.org\/10.1210\/endrev\/bnab016","journal-title":"Endocr Rev"},{"key":"7245_CR2","doi-asserted-by":"publisher","first-page":"227","DOI":"10.1016\/S0140-6736(22)01330-7","volume":"401","author":"MK Auer","year":"2023","unstructured":"Auer MK, Nordenstr\u00f6m A, Lajic S, Reisch N (2023) Congenital adrenal hyperplasia. Lancet 401:227\u2013244. https:\/\/doi.org\/10.1016\/S0140-6736(22)01330-7","journal-title":"Lancet"},{"key":"7245_CR3","doi-asserted-by":"publisher","first-page":"2088","DOI":"10.1002\/art.42646","volume":"75","author":"MB Humphrey","year":"2023","unstructured":"Humphrey MB, Russell L, Danila MI, Fink HA, Guyatt G, Cannon M, Caplan L, Gore S, Grossman J, Hansen KE, Lane NE, Ma NS, Magrey M, McAlindon T, Robinson AB, Saha S, Womack C, Abdulhadi B, Charles JF, Cheah JTL, Chou S, Goyal I, Haseltine K, Jackson L, Mirza R, Moledina I, Punni E, Rinden T, Turgunbaev M, Wysham K, Turner AS, Uhl S (2023) 2022 American College of Rheumatology guideline for the prevention and treatment of glucocorticoid-induced osteoporosis. Arthritis Rheumatol 75:2088\u20132102. https:\/\/doi.org\/10.1002\/art.42646","journal-title":"Arthritis Rheumatol"},{"key":"7245_CR4","doi-asserted-by":"publisher","first-page":"CD012517","DOI":"10.1002\/14651858.CD012517.pub2","volume":"3","author":"SM Ng","year":"2020","unstructured":"Ng SM, Stepien KM, Krishan A (2020) Glucocorticoid replacement regimens for treating congenital adrenal hyperplasia. Cochrane Database Syst Rev 3:CD012517. https:\/\/doi.org\/10.1002\/14651858.CD012517.pub2","journal-title":"Cochrane Database Syst Rev"},{"key":"7245_CR5","doi-asserted-by":"publisher","first-page":"995","DOI":"10.1007\/s12020-014-0332-9","volume":"48","author":"M Delvecchio","year":"2015","unstructured":"Delvecchio M, Soldano L, Lonero A, Ventura A, Giordano P, Cavallo L, Grano M, Brunetti G, Faienza MF (2015) Evaluation of impact of steroid replacement treatment on bone health in children with 21-hydroxylase deficiency. Endocrine 48:995\u20131000. https:\/\/doi.org\/10.1007\/s12020-014-0332-9","journal-title":"Endocrine"},{"key":"7245_CR6","doi-asserted-by":"publisher","first-page":"535","DOI":"10.1046\/j.1365-2265.1996.00851.x","volume":"45","author":"CY Guo","year":"1996","unstructured":"Guo CY, Weetman AP, Eastell R (1996) Bone turnover and bone mineral density in patients with congenital adrenal hyperplasia. Clin Endocrinol (Oxf) 45:535\u2013541. https:\/\/doi.org\/10.1046\/j.1365-2265.1996.00851.x","journal-title":"Clin Endocrinol (Oxf)"},{"key":"7245_CR7","doi-asserted-by":"publisher","first-page":"813","DOI":"10.1111\/cen.13580","volume":"88","author":"A Halper","year":"2018","unstructured":"Halper A, Sanchez B, Hodges JS, Kelly AS, Dengel D, Nathan BM, Petryk A, Sarafoglou K (2018) Bone mineral density and body composition in children with congenital adrenal hyperplasia. Clin Endocrinol (Oxf) 88:813\u2013819. https:\/\/doi.org\/10.1111\/cen.13580","journal-title":"Clin Endocrinol (Oxf)"},{"key":"7245_CR8","doi-asserted-by":"publisher","first-page":"493","DOI":"10.3389\/fendo.2020.00493","volume":"11","author":"S Rangaswamaiah","year":"2020","unstructured":"Rangaswamaiah S, Gangathimmaiah V, Nordenstrom A, Falhammar H (2020) Bone mineral density in adults with congenital adrenal hyperplasia: a systematic review and meta-analysis. Front Endocrinol (Lausanne) 11:493. https:\/\/doi.org\/10.3389\/fendo.2020.00493","journal-title":"Front Endocrinol (Lausanne)"},{"key":"7245_CR9","doi-asserted-by":"publisher","first-page":"330","DOI":"10.1111\/cen.12507","volume":"82","author":"D El-Maouche","year":"2015","unstructured":"El-Maouche D, Collier S, Prasad M, Reynolds JC, Merke DP (2015) Cortical bone mineral density in patients with congenital adrenal hyperplasia due to 21-hydroxylase deficiency. Clin Endocrinol (Oxf) 82:330\u2013337. https:\/\/doi.org\/10.1111\/cen.12507","journal-title":"Clin Endocrinol (Oxf)"},{"key":"7245_CR10","doi-asserted-by":"publisher","first-page":"477","DOI":"10.1111\/j.1365-2265.2008.03518.x","volume":"71","author":"A Zimmermann","year":"2009","unstructured":"Zimmermann A, Sido PG, Schulze E, Al Khzouz C, Lazea C, Coldea C, Weber MM (2009) Bone mineral density and bone turnover in Romanian children and young adults with classical 21-hydroxylase deficiency are influenced by glucocorticoid replacement therapy. Clin Endocrinol (Oxf) 71:477\u2013484. https:\/\/doi.org\/10.1111\/j.1365-2265.2008.03518.x","journal-title":"Clin Endocrinol (Oxf)"},{"key":"7245_CR11","doi-asserted-by":"publisher","first-page":"9141","DOI":"10.1021\/acs.jpcb.7b06687","volume":"121","author":"A Munasinghe","year":"2017","unstructured":"Munasinghe A, Lin P, Colina CM (2017) Unraveling binding interactions between human RANKL and its decoy receptor osteoprotegerin. J Phys Chem B 121:9141\u20139148. https:\/\/doi.org\/10.1021\/acs.jpcb.7b06687","journal-title":"J Phys Chem B"},{"key":"7245_CR12","doi-asserted-by":"publisher","first-page":"139","DOI":"10.1016\/j.abb.2008.03.018","volume":"473","author":"BF Boyce","year":"2008","unstructured":"Boyce BF, Xing L (2008) Functions of RANKL\/RANK\/OPG in bone modeling and remodeling. Arch Biochem Biophys 473:139\u2013146. https:\/\/doi.org\/10.1016\/j.abb.2008.03.018","journal-title":"Arch Biochem Biophys"},{"key":"7245_CR13","doi-asserted-by":"publisher","first-page":"4440","DOI":"10.3390\/jcm12134440","volume":"12","author":"V Gerov","year":"2023","unstructured":"Gerov V, Gerova D, Micheva I, Nikolova M, Mihaylova G, Galunska B (2023) Dynamics of bone disease diomarkers Dickkopf-1 and sclerostin in patients with multiple myeloma. J Clin Med 12:4440. https:\/\/doi.org\/10.3390\/jcm12134440","journal-title":"J Clin Med"},{"key":"7245_CR14","doi-asserted-by":"publisher","first-page":"4","DOI":"10.1007\/s12519-018-0198-7","volume":"15","author":"G Brunetti","year":"2019","unstructured":"Brunetti G, D\u2019Amato G, Chiarito M, Tullo A, Colaianni G, Colucci S, Grano M, Faienza MF (2019) An update on the role of RANKL\u2013RANK\/osteoprotegerin and WNT-\u00df-catenin signaling pathways in pediatric diseases. World J Pediatr 15:4\u201311. https:\/\/doi.org\/10.1007\/s12519-018-0198-7","journal-title":"World J Pediatr"},{"key":"7245_CR15","doi-asserted-by":"publisher","first-page":"29","DOI":"10.1016\/j.bone.2016.10.007","volume":"96","author":"J Delgado-Calle","year":"2017","unstructured":"Delgado-Calle J, Sato AY, Bellido T (2017) Role and mechanism of action of sclerostin in bone. Bone 96:29\u201337. https:\/\/doi.org\/10.1016\/j.bone.2016.10.007","journal-title":"Bone"},{"key":"7245_CR16","doi-asserted-by":"publisher","first-page":"170","DOI":"10.1136\/adc.51.3.170","volume":"51","author":"JM Tanner","year":"1976","unstructured":"Tanner JM, Whitehouse RH (1976) Clinical longitudinal standards for height, weight, height velocity, weight velocity, and stages of puberty. Arch Dis Child 51:170\u2013179. https:\/\/doi.org\/10.1136\/adc.51.3.170","journal-title":"Arch Dis Child"},{"key":"7245_CR17","doi-asserted-by":"publisher","first-page":"654","DOI":"10.1097\/MPG.0000000000000274","volume":"58","author":"G Karag\u00fczel","year":"2014","unstructured":"Karag\u00fczel G, Dilber B, \u00c7an G, \u00d6kten A, De\u011fer O, Holick MF (2014) Seasonal vitamin D status of healthy schoolchildren and predictors of low vitamin D status. J Pediatr Gastroenterol Nutr 58:654\u2013660. https:\/\/doi.org\/10.1097\/MPG.0000000000000274","journal-title":"J Pediatr Gastroenterol Nutr"},{"key":"7245_CR18","doi-asserted-by":"publisher","first-page":"104","DOI":"10.5114\/aoms.2010.13516","volume":"6","author":"SMA El Dayem","year":"2010","unstructured":"El Dayem SMA, Anwar GM, Salama H, Kamel AF, Emara N (2010) Bone mineral density, bone turnover markers, lean mass, and fat mass in Egyptian children with congenital adrenal hyperplasia. Arch Med Sci 6:104\u2013110. https:\/\/doi.org\/10.5114\/aoms.2010.13516","journal-title":"Arch Med Sci"},{"key":"7245_CR19","doi-asserted-by":"publisher","first-page":"1123","DOI":"10.1007\/s00198-011-1669-z","volume":"23","author":"S Kirmani","year":"2012","unstructured":"Kirmani S, Amin S, McCready LK, Atkinson EJ, Melton LJ 3rd, M\u00fcller R, Khosla S (2012) Sclerostin levels during growth in children. Osteoporos Int 23:1123\u20131130. https:\/\/doi.org\/10.1007\/s00198-011-1669-z","journal-title":"Osteoporos Int"},{"key":"7245_CR20","doi-asserted-by":"publisher","first-page":"27","DOI":"10.1002\/jbmr.128","volume":"26","author":"UI Modder","year":"2011","unstructured":"Modder UI, Clowes JA, Hoey K, Peterson JM, McCready L, Oursler MJ, Riggs BL, Khosla S (2011) Regulation of circulating sclerostin levels by sex steroids in women and in men. J Bone Miner Res 26:27\u201334. https:\/\/doi.org\/10.1002\/jbmr.128","journal-title":"J Bone Miner Res"},{"key":"7245_CR21","doi-asserted-by":"publisher","first-page":"57","DOI":"10.3389\/fcell.2020.00057","volume":"8","author":"Y Xu","year":"2020","unstructured":"Xu Y, Gao C, He J, Gu W, Yi C, Chen B, Wang Q, Tang F, Xu J, Yue H, Zhang Z (2020) Sclerostin and its associations with bone metabolism markers and sex hormones in healthy community-dwelling elderly individuals and adolescents. Front Cell Dev Biol 8:57\u201364. https:\/\/doi.org\/10.3389\/fcell.2020.00057","journal-title":"Front Cell Dev Biol"},{"key":"7245_CR22","doi-asserted-by":"publisher","first-page":"289","DOI":"10.1111\/pedi.12288","volume":"17","author":"C Tsentidis","year":"2016","unstructured":"Tsentidis C, Gourgiotis D, Kossiva L, Marmarinos A, Doulgeraki A, Karavanaki K (2016) Sclerostin distribution in children and adolescents with type 1 diabetes mellitus and correlation with bone metabolism and bone mineral density. Pediatr Diabetes 17:289\u2013299. https:\/\/doi.org\/10.1111\/pedi.12288","journal-title":"Pediatr Diabetes"},{"key":"7245_CR23","doi-asserted-by":"publisher","first-page":"221","DOI":"10.1016\/j.beem.2008.09.010","volume":"23","author":"M Debono","year":"2009","unstructured":"Debono M, Price JN, Ross RJ (2009) Novel strategies for hydrocortisone replacement. Best Pract Res Clin Endocrinol Metab 23:221\u2013232. https:\/\/doi.org\/10.1016\/j.beem.2008.09.010","journal-title":"Best Pract Res Clin Endocrinol Metab"},{"key":"7245_CR24","doi-asserted-by":"publisher","first-page":"519","DOI":"10.1210\/er.2018-00097","volume":"39","author":"RS Hardy","year":"2018","unstructured":"Hardy RS, Zhou H, Seibel MJ, Cooper MS (2018) Glucocorticoids and bone: consequences of endogenous and exogenous excess and replacement therapy. Endocr Rev 39:519\u2013548. https:\/\/doi.org\/10.1210\/er.2018-00097","journal-title":"Endocr Rev"},{"key":"7245_CR25","doi-asserted-by":"publisher","first-page":"59","DOI":"10.1016\/S2213-8587(13)70045-7","volume":"1","author":"MJ Seibel","year":"2013","unstructured":"Seibel MJ, Cooper MS, Zhou H (2013) Glucocorticoid-induced osteoporosis: mechanisms, management, and future perspectives. Lancet Diabetes Endocrinol 1:59\u201370. https:\/\/doi.org\/10.1016\/S2213-8587(13)70045-7","journal-title":"Lancet Diabetes Endocrinol"},{"key":"7245_CR26","doi-asserted-by":"publisher","first-page":"2269","DOI":"10.1210\/jc.2008-2446","volume":"94","author":"MF Faienza","year":"2009","unstructured":"Faienza MF, Brunetti G, Colucci S, Piacente L, Ciccarelli M, Giordani L, Del Vecchio GC, D\u2019Amore M, Albanese L, Cavallo L, Grano M (2009) Osteoclastogenesis in children with 21-hydroxylase deficiency on long-term glucocorticoid therapy: the role of receptor activator of nuclear factor-\u03baB ligand\/osteoprotegerin imbalance. J Clin Endocrinol Metab 94:2269\u20132276. https:\/\/doi.org\/10.1210\/jc.2008-2446","journal-title":"J Clin Endocrinol Metab"},{"key":"7245_CR27","doi-asserted-by":"publisher","first-page":"98","DOI":"10.1007\/s11914-005-0017-7","volume":"3","author":"E Canalis","year":"2005","unstructured":"Canalis E (2005) Mechanisms of glucocorticoid action in bone. Curr Osteoporos Rep 3:98\u2013102. https:\/\/doi.org\/10.1007\/s11914-005-0017-7","journal-title":"Curr Osteoporos Rep"},{"key":"7245_CR28","doi-asserted-by":"publisher","first-page":"3816","DOI":"10.1210\/jc.2003-030088","volume":"88","author":"M Misra","year":"2003","unstructured":"Misra M, Soyka LA, Miller KK, Herzog DB, Grinspoon S, De Chen D, Neubauer G, Klibanski A (2003) Serum osteoprotegerin in adolescent girls with anorexia nervosa. J Clin Endocrinol Metab 88:3816\u20133822. https:\/\/doi.org\/10.1210\/jc.2003-030088","journal-title":"J Clin Endocrinol Metab"},{"key":"7245_CR29","doi-asserted-by":"publisher","first-page":"1317","DOI":"10.2147\/CIA.S115472","volume":"11","author":"NV Mohamad","year":"2016","unstructured":"Mohamad NV, Soelaiman IN, Chin KY (2016) A concise review of testosterone and bone health. Clin Interv Aging 11:1317\u20131324. https:\/\/doi.org\/10.2147\/CIA.S115472","journal-title":"Clin Interv Aging"},{"key":"7245_CR30","doi-asserted-by":"publisher","first-page":"e11410","DOI":"10.1371\/journal.pone.0011410","volume":"5","author":"W Yao","year":"2010","unstructured":"Yao W, Dai W, Shahnazari M, Pham A, Chen Z, Chen H, Guan M, Lane NE (2010) Inhibition of the progesterone nuclear receptor during the bone linear growth phase increases peak bone mass in female mice. PLoS ONE 5:e11410. https:\/\/doi.org\/10.1371\/journal.pone.0011410","journal-title":"PLoS ONE"},{"key":"7245_CR31","doi-asserted-by":"publisher","first-page":"586","DOI":"10.5114\/aoms.2020.99624","volume":"19","author":"R Plinta","year":"2020","unstructured":"Plinta R, Czajkowska M, Pisula M, Brz\u0119k A, Knapik A, Olszanecka-Glinianowicz M, Skrzypulec-Plinta V (2020) The effect of regular fitness training, sex hormones, and turnover of selected bone markers on sclerostin levels in young women. Arch Med Sci 19:586\u2013592. https:\/\/doi.org\/10.5114\/aoms.2020.99624","journal-title":"Arch Med Sci"},{"key":"7245_CR32","doi-asserted-by":"publisher","first-page":"E920","DOI":"10.1210\/jc.2013-3852","volume":"99","author":"T Palomo","year":"2014","unstructured":"Palomo T, Glorieux FH, Rauch F (2014) Circulating sclerostin in children and young adults with heritable bone disorders. J Clin Endocrinol Metab 99:E920\u2013E925. https:\/\/doi.org\/10.1210\/jc.2013-3852","journal-title":"J Clin Endocrinol Metab"},{"key":"7245_CR33","doi-asserted-by":"publisher","first-page":"226","DOI":"10.1093\/ndt\/gfr270","volume":"27","author":"D Cejka","year":"2012","unstructured":"Cejka D, J\u00e4ger-Lansky A, Kieweg H, Weber M, Bieglmayer C, Haider DG, Diarra D, Patsch JM, Kainberger F, Bohle B, Haas M (2012) Sclerostin serum levels correlate positively with bone mineral density and microarchitecture in haemodialysis patients. Nephrol Dial Transplant 27:226\u2013230. https:\/\/doi.org\/10.1093\/ndt\/gfr270","journal-title":"Nephrol Dial Transplant"},{"key":"7245_CR34","unstructured":"Akeson PK, Akesson KE, Lind T, Hernell O, Silfverdal S, Ohlund I (2018) Vitamin D intervention and bone: a randomized clinical trial in fair- and dark-skinned children at northern latitudes. J Pediatr"}],"container-title":["European Journal of Pediatrics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00431-026-07245-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00431-026-07245-2","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00431-026-07245-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,11]],"date-time":"2026-08-11T03:50:03Z","timestamp":1786420203000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00431-026-07245-2"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,7,20]]},"references-count":34,"journal-issue":{"issue":"8","published-online":{"date-parts":[[2026,8]]}},"alternative-id":["7245"],"URL":"https:\/\/doi.org\/10.1007\/s00431-026-07245-2","relation":{},"ISSN":["1432-1076"],"issn-type":[{"value":"1432-1076","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,7,20]]},"assertion":[{"value":"8 March 2026","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"12 June 2026","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"6 July 2026","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"20 July 2026","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","label":"Conflicts of interest","group":{"name":"EthicsHeading","label":"Declarations"}}],"article-number":"590"}}